{"input_url":"https://www.frontiersin.org/journals/urology/articles/10.3389/fruro.2026.1855180/full","gnews_decode":"https://www.frontiersin.org/journals/urology/articles/10.3389/fruro.2026.1855180/full","http_status":200,"final_url":"https://www.frontiersin.org/journals/urology/articles/10.3389/fruro.2026.1855180/full","html_length":980479,"trafilatura_result":"ok","text_length":50847,"text_preview":"Abstract\nPatients with prostate cancer (PCa) undergoing androgen deprivation therapy (ADT) frequently develop cardiometabolic complications, particularly those with type 2 diabetes (T2D). Glucagon-like peptide-1 receptor agonists (GLP-1RAs) provide cardiovascular and renal benefits in diabetic popul","verdict":"OK"}